搜索筛选:
搜索耗时0.0921秒,为你在为你在102,285,761篇论文里面共找到 5 篇相符的论文内容
发布年度:
[期刊论文] 作者：Ye YU,Jing-feng JING,Xian-kun TONG,Pei-lan HE,Yuan-chao LI,You-hong HU,Wei TANG,
来源：中国药理学报（英文版） 年份：2014
...
,Isothiafludine, a novel non-nucleoside compound,inhibits hepatitis B virus replication through bloc
[期刊论文] 作者：Li YANG,Li-ping SHI,Hai-jun CHEN,Xian-kun TONG,Gui-feng WANG,Yang-ming ZHANG,Wen-long WANG,
来源：中国药理学报（英文版） 年份：2014
...
[期刊论文] 作者：Heng Li,Li Yang,Fei-fei Liu,Xin-na Ma,Pei-lan He,Wei Tang,Xian-kun Tong,Jian-ping Zuo,
来源：中国药理学报（英文版） 年份：2020
Since the outbreak of novel coronavirus pneumonia (COVID-19) in December 2019,more than 2,500,000 people worldwide have been diagnosed with SARS-CoV-2 as of Apr...
[期刊论文] 作者：Xian-kun TONG,Hong QIU,Xin ZHANG,Li-ping SHI,Gui-feng WANG,Fei-hong JI,Hui-yong DING,Wei TANG,Kan DING,
来源：中国药理学报（英文版） 年份：2010
...
[期刊论文] 作者：Heng Li,Xin-na Ma,Yu Zhou,Feng-hua Zhu,Pei-Ian He,Wei Tang,Ye-cheng Zhang,Jin Xiong,Shu-qi Xiao,Xian-kun Tong,
来源：中国药理学报（英文版） 年份：2021
To discover effective drugs for COVID-19 treatment amongst already clinically approved drugs,we developed a high throughput screening assay for SARS-CoV-2 virus entry inhibitors using SARS2-S pseudotyped virus.An approved drug library of 18......
相关搜索：
